Brand names: Ozempic (diabetes), Wegovy (obesity)
Important considerations : These strategies support overall metabolic health but should not be viewed as substitutes for medical treatment when indicated
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
This supplement contains 16 billion CFUs from unique bacterial strains not often seen elsewhere, and its designed to support gut health, including reducing constipation and bloating
superior to Semaglutide in fat burning, blood sugar control, and heart health
We identified patents and their patent family members that could either be used to deter other branded competitors from upstream research and development of competing similar products (e.g., me-too versions), or which could be used downstream to block/delay generic entrants